419 related articles for article (PubMed ID: 18409534)
1. [Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines].
Kodama M; Murakami K; Okimoto T; Fujioka T
Nihon Rinsho; 2008 Apr; 66(4):804-10. PubMed ID: 18409534
[TBL] [Abstract][Full Text] [Related]
2. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
[TBL] [Abstract][Full Text] [Related]
3. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
4. [Recent guidelines for the management of Helicobacter pylori infection].
Kato M; Hokari K; Kagaya H; Takeda H; Sugiyama T; Asaka M
Nihon Rinsho; 2001 Feb; 59(2):246-51. PubMed ID: 11218393
[TBL] [Abstract][Full Text] [Related]
5. [Guidelines in the management of Helicobacter pylori infection in Japan--in comparison with the guidelines published in other countries].
Shimada T; Yoneda M; Hiraishi H; Terano A
Nihon Rinsho; 2003 Jan; 61(1):7-12. PubMed ID: 12607307
[TBL] [Abstract][Full Text] [Related]
6. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
7. [Indication of H. pylori eradication therapy].
Ohtaka K; Miwa H; Sato N
Nihon Rinsho; 2003 Jan; 61(1):97-101. PubMed ID: 12607324
[TBL] [Abstract][Full Text] [Related]
8. [Helicobacter pylori: reasons for eradication].
Schuster M
Praxis (Bern 1994); 2004 Dec; 93(51-52):2135-41. PubMed ID: 15672764
[TBL] [Abstract][Full Text] [Related]
9. Key points from the revised Maastricht Consensus Report: the impact on general practice.
Bazzoli F
Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S3-7. PubMed ID: 11686230
[TBL] [Abstract][Full Text] [Related]
10. Management of Helicobacter pylori-related disorders.
Misiewicz JJ
Eur J Gastroenterol Hepatol; 1997 Apr; 9 Suppl 1():S17-20; discussion S20-1, S27-9. PubMed ID: 9160212
[TBL] [Abstract][Full Text] [Related]
11. [Indication of H. pylori eradication therapy--who should be treated?].
Miwa H; Sato N
Nihon Rinsho; 2001 Feb; 59(2):301-7. PubMed ID: 11218402
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
[TBL] [Abstract][Full Text] [Related]
13. The Korean perspective of Helicobacter pylori infection: lessons from the Japanese government's policy to prevent gastric cancer.
Park JM; Hahm KB
Dig Dis; 2014; 32(3):290-4. PubMed ID: 24732195
[TBL] [Abstract][Full Text] [Related]
14. New guidelines for Helicobacter pylori: applying them to your practice.
Nimish V
Rev Gastroenterol Disord; 2007; 7(3):111-4. PubMed ID: 17928790
[TBL] [Abstract][Full Text] [Related]
15. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
17. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
18. [Eradication therapy of Helicobacter pylori for elderly patients in Japan].
Nakamura T; Terano A
Nihon Rinsho; 2002 Aug; 60(8):1566-72. PubMed ID: 12187752
[TBL] [Abstract][Full Text] [Related]
19. [Helicobacter pylori in peptic ulcer and gastric cancer].
Matsukura N; Onda M; Yamashita K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori. Update 2002].
Schuster MJ
Praxis (Bern 1994); 2002 Nov; 91(48):2093-9. PubMed ID: 12508673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
